» Articles » PMID: 25687977

The Influences of Whole Brain Radiotherapy on Social Cognition and Association with Hippocampal and Frontal Dosimetry

Overview
Journal Psychiatr Q
Specialty Psychiatry
Date 2015 Feb 18
PMID 25687977
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The influence of brain radiotherapy on neurocognition is a major concern. Social cognition is a mental process in the meaning of social interaction and the recognition of facial emotion is a domain of social cognition. Thus, we aimed to investigate the early effect of whole brain radiotherapy on facial emotion recognition ability. Thirteen patients with various brain tumors in the study. Beck depression and anxiety inventory and the facial emotion recognition test by using a set of photographs were performed at the beginning and post radiotherapy. The severity of depression (16.40 ± 12.16 vs 04.00 ± 02.38 points) and anxiety (14.47 ± 11.96 vs 04.54 ± 03.30 points) were significantly higher in patients. The only significance according to facial emotion recognition rate between initial phase of patients and healthy controls was identifying neutral facial em otion (p = 0.002). The patients after brain radiotherapy had significantly better rate of recognizing fear facial emotions (p = 0.039). This study is the first that investigated the effects of cranial irradiation on facial emotion recognition ability and compares this ability with healthy controls. Interestingly, in the early phase the patients seem to be improved in fear facial emotion after brain radiotherapy without sparing cognition specific regions as hippocampus and frontal regions.

Citing Articles

Association of Radiation Dose to the Amygdala-Orbitofrontal Network with Emotion Recognition Task Performance in Patients with Low-Grade and Benign Brain Tumors.

Hardy S, Finkelstein A, Milano M, Schifitto G, Sun H, Holley K Cancers (Basel). 2023; 15(23).

PMID: 38067248 PMC: 10705220. DOI: 10.3390/cancers15235544.


Sociocognitive Functioning and Psychosocial Burden in Patients with Brain Tumors.

Pertz M, Schlegel U, Thoma P Cancers (Basel). 2022; 14(3).

PMID: 35159034 PMC: 8833643. DOI: 10.3390/cancers14030767.

References
1.
Peluso M, Glahn D, Matsuo K, Serap Monkul E, Najt P, Zamarripa F . Amygdala hyperactivation in untreated depressed individuals. Psychiatry Res. 2009; 173(2):158-61. PMC: 2720603. DOI: 10.1016/j.pscychresns.2009.03.006. View

2.
Coupland N, Sustrik R, Ting P, Li D, Hartfeil M, Singh A . Positive and negative affect differentially influence identification of facial emotions. Depress Anxiety. 2004; 19(1):31-4. DOI: 10.1002/da.10136. View

3.
Danysz W, Parsons C, Schwaier A, Popik P, Wedzony K, Lazarewicz J . GlycineB antagonists as potential therapeutic agents. Previous hopes and present reality. Amino Acids. 1999; 14(1-3):235-9. DOI: 10.1007/BF01345268. View

4.
Peacock K, Lesser G . Current therapeutic approaches in patients with brain metastases. Curr Treat Options Oncol. 2006; 7(6):479-89. DOI: 10.1007/s11864-006-0023-8. View

5.
Orgeta V . Emotion recognition ability and mild depressive symptoms in late adulthood. Exp Aging Res. 2014; 40(1):1-12. DOI: 10.1080/0361073X.2014.857535. View